Regis Technologies
Michael Drolet is a Senior Research Scientist in Process Chemistry at Regis Technologies, Inc., since February 2019, where responsibilities include partnering with pharmaceutical and biotechnology companies to expedite drug candidates to market. Previously, Michael served as a Postdoctoral Research Assistant at Purdue University from November 2011 to July 2018, advising graduate students on chemical propulsion technologies, guiding research on hypergolic fuels, and writing research proposals. Michael also worked as a Graduate Research Assistant at Purdue University, focusing on synthetic methodologies and exploring new synthetic routes. Michael holds a PhD in Organic Chemistry from Purdue University and a BS in Chemistry from the University of Illinois Urbana-Champaign.
Regis Technologies
Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help advance drug candidates to market. Our services streamline and support your discovery, lead molecule development and drug commercialization – from process development and analytical development, to stability services and cGMP API manufacturing. Our facilities are routinely inspected by the FDA and other global regulatory authorities. With our extensive organic chemistry & separations expertise, Regis also manufactures an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956.